Angela M Wisniewski1, Michael R Dlugosz, Richard D Blondell. 1. Department of Family Medicine, School of Medicine and Biomedical Sciences, and Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14203, USA. amw25@buffalo.edu
Abstract
UNLABELLED: ABSTRACT Background: Physician acceptance of cash payment and low adherence to practice guidelines may contribute to buprenorphine-naloxone diversion. The purpose of this study was to investigate the clinical practice policies of physicians who provide office-based treatment for opioid dependence with buprenorphine-naloxone. METHODS: Data were obtained from 31 of 71 practices surveyed (response rate 43.7%) that provided answers to at least some of the survey questions. RESULTS: Of these practices, 28 (90.3%) accepted cash as payment and 6 (19.4%) accepted only cash for treatment services. Analysis of open-ended responses to questions about office policies revealed wide variation among practices and overall suboptimal adherence to recommended treatment guidelines. CONCLUSIONS: These results underscore the need for continuing education for physicians who prescribe buprenorphine-naloxone.
UNLABELLED: ABSTRACT Background: Physician acceptance of cash payment and low adherence to practice guidelines may contribute to buprenorphine-naloxone diversion. The purpose of this study was to investigate the clinical practice policies of physicians who provide office-based treatment for opioid dependence with buprenorphine-naloxone. METHODS: Data were obtained from 31 of 71 practices surveyed (response rate 43.7%) that provided answers to at least some of the survey questions. RESULTS: Of these practices, 28 (90.3%) accepted cash as payment and 6 (19.4%) accepted only cash for treatment services. Analysis of open-ended responses to questions about office policies revealed wide variation among practices and overall suboptimal adherence to recommended treatment guidelines. CONCLUSIONS: These results underscore the need for continuing education for physicians who prescribe buprenorphine-naloxone.
Authors: Bradley D Stein; Rosalie Liccardo Pacula; Adam J Gordon; Rachel M Burns; Douglas L Leslie; Mark J Sorbero; Sebastian Bauhoff; Todd W Mandell; Andrew W Dick Journal: Milbank Q Date: 2015-09 Impact factor: 4.911
Authors: Morgane Guillou Landreat; Charles Rozaire; Jean Yves Guillet; Caroline Victorri Vigneau; Jean Yves Le Reste; Marie Grall Bronnec Journal: PLoS One Date: 2015-10-19 Impact factor: 3.240
Authors: Theodore V Parran; Joseph Z Muller; Elina Chernyak; Chris Adelman; Christina M Delos Reyes; Douglas Rowland; Mykola Kolganov Journal: Subst Abuse Date: 2017-06-13
Authors: Morgane Guillou-Landreat; Philippe Levassor; Marylène Guerlais; Veronique Sebille; Caroline Victorri-Vigneau Journal: Int J Environ Res Public Health Date: 2021-05-27 Impact factor: 3.390